Farnesyl-Diphosphate Farnesyltransferase, antagonists & inhibitors
- Name
- Farnesyl-Diphosphate Farnesyltransferase, antagonists & inhibitors
- Accession Number
- DBCAT001690
- Description
Not Available
- Drugs
Drug Drug Description TAK-475 Investigated for use/treatment in hyperlipidemia. Lapaquistat Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.). - Drugs & Drug Targets
Drug Target Type TAK-475 Squalene synthase target TAK-475 3-hydroxy-3-methylglutaryl-coenzyme A reductase target